Bayer Leverkusen, Arsenal and Champions League
Digest more
With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population of patients with chronic kidney disease. | Kerendia, also known as finerenone,
Mikel Arteta could be without his starting right back for Tuesday’s second leg.
By Patricia Weiss and Ludwig Burger FRANKFURT, March 4 (Reuters) - Germany's Bayer issued a 2026 earnings target range below market expectations on Wednesday, as the drugmaker's CEO struggles to revive a stock battered by costly litigation and massive financial debt.
Commercial planting for newgold canola will start in September 2027 in the southern Great Plains (Kansas, Oklahoma, northern Texas), primarily within wheat rotation systems. At the intersection of low-carbon fuels and practical farm economics, Bayer’s ...
A special award for special social commitment. At this year's ceremony for the Sepp Herberger Awards in Wolfsburg on Monday night, the DFB Sepp Herberger Foundation recognised Bayer 04 in the social rehabilitation category.
By Diana Novak Jones March 4 (Reuters) - A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer's Roundup weedkiller causes cancer.
Clinical Trials Arena on MSN
Bayer eyes label expansion on phase III non-diabetic CKD win
If Kerendia secures a label expansion, it would become available to more than half of the overall CKD patient population who have a non-diabetic form of the disease.